Morabito F, Tripepi G, Del Poeta G, Mauro FR, et al. Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine. Results of study on 486 cases outside clinical trials. Am J Hematol 2021 Apr 20. doi: 10.1002/ajh.26201.
PMID: 33878220